Novocure announced that management will participate in two upcoming investor events
Published
Signal category
Presence & Recognition
Quote
“management will participate in two upcoming investor events”
— Novocure team
Company
Novocure
working to extend survival in some of the most aggressive forms of cancer
- Industry
- Medical Equipment Manufacturing
- Location
- Baar, CH
- Company size
- 1,514 employees
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic cancer. Novocure’s global headquarters is located in Baar, Switzerland, with U.S. headquarters located in Portsmouth, New Hampshire and research and development facilities located in Haifa, Israel. For additional information about the company, please visit Novocure.com.
Founded 2000